### In vitro / physico-chemical Data <a id="invitro-and-physico-chemical-data"></a>

A literature search was performed to collect available information on physicochemical properties of paracetamol. The obtained information from literature is summarized in the table below. 

| **Parameter**   | **Unit** | **Value** | Source                                     | **Description**                                 |
| :-------------- | -------- | --------- | ------------------------------------------ | ----------------------------------------------- |
| **Paracetamol**   |  |  |  | |
| MW              | g/mol    |  151.16         | [Mian 2020](#main-references)               | Molecular weight|
| fu              |   | 0.82    | [Mian 2020](#main-references)                 | Fraction unbound in plasma, albumin binding partner unknown                  |
| pK<sub>a</sub>  | |9.41| [Mian 2020](#main-references)          | Acid dissociation constant                      |
| Solubility (pH) |    mg/ml    |   17.314 (7.00)          | [Mian 2020](#main-references)            | Aqueous Solubility
| **Paracetamol glucuronide**   |  |  |  | |
| MW              | g/mol    |  327.29         | [Mian 2020](#main-references)               | Molecular weight|
| logP            |    | -1               | [Mian 2020](#main-references) | Partition coefficient between octanol and water |
| fu              |     |0.92            | [Mian 2020](#main-references)                 | Fraction unbound in plasma, major binding partner unknown              |
| pK<sub>a</sub>  | |3.17| [Mian 2020](#main-references)          | Acid dissociation constant                      |
| Solubility (pH) |    mg/ml    |   20.770 (7.00)          | [Mian 2020](#main-references)            | Aqueous Solubility
| **Paracetamol sulfate**   |  |  |  | |
| MW              | g/mol    |  231.23         | [Mian 2020](#main-references)               | Molecular weight|
| logP            |    | -1                | [Mian 2020](#main-references) | Partition coefficient between octanol and water |
| fu          |    | 0.46                   | [Mian 2020](#main-references)                 | Fraction unbound in plasma, major binding partner unknown                    |
| pK<sub>a</sub>  | |2.20| [Mian 2020](#main-references)          | Acid dissociation constant                      |
| Solubility (pH) |    mg/ml    |   1.540 (7.00)          | [Mian 2020](#main-references)            | Aqueous Solubility
| **NAPQI**   |  |  |  | |
| MW              | g/mol    |  231.23         | [Mian 2020](#main-references)               | Molecular weight|
| logP            |    | -1                | [Mian 2020](#main-references) | Partition coefficient between octanol and water |
| fu          |    | 0.46                   | [Mian 2020](#main-references)                 | Fraction unbound in plasma, major binding partner unknown                    |
| pK<sub>a</sub>  | |2.20| [Mian 2020](#main-references)          | Acid dissociation constant                      |
| Solubility (pH) |    mg/ml    |   1.540 (7.00)          | [Mian 2020](#main-references)            | Aqueous Solubility
| **Methocyacetaminophen**   |  |  |  | |
| MW              | g/mol    |  231.23         | [Mian 2020](#main-references)               | Molecular weight|
| logP            |    | -1                | [Mian 2020](#main-references) | Partition coefficient between octanol and water |
| fu          |    | 0.46                   | [Mian 2020](#main-references)                 | Fraction unbound in plasma, major binding partner unknown                    |
| pK<sub>a</sub>  | |2.20| [Mian 2020](#main-references)          | Acid dissociation constant                      |
| Solubility (pH) |    mg/ml    |   1.540 (7.00)          | [Mian 2020](#main-references)            | Aqueous Solubility

### Clinical Data  <a id="clinical-data"></a>

A literature search was performed to collect available clinical data on paracetamol and its metabolites in healthy adults.

#### Model Building <a id="model-building"></a>

The following studies were used for model building and evaluation:

| Publication                 | Dose | Route| Dosing | Formulation
| :---------------|----------- |-------| -------|---------- |
| [Clements 1984](#main-references) | 5 mg/kg | IV|single-dose
| [Prescott 1980](#main-references) | 12 mg/Kg | IV|single-dose
| [Clements 1984](#main-references) | 20 mg/kg | IV|single-dose
| [Divoll 1982](#main-references) | 650 mg | IV|single-dose
| [Liukas 2011](#main-references) | 1000 mg | IV  | single-dose
| [Clements 1984](#main-references) | 5 mg/kg | Oral | single-dose, fasted-state |IR/dissolved
| [Prescott 1980](#main-references) | 12 mg/Kg | Oral|single-dose, fasted-state|IR/dissolved
| [Prescott 1980](#main-references) | 20 mg/Kg | Oral| single-dose, fasted-state|IR/dissolved|
| [Clements 1984](#main-references) | 20 mg/kg | Oral| single-dose, fasted-state| IR/dissolved formulation   |
| [van der Veen 1994](#main-references) | 300 mg | Oral|single-dose, fasted-state| IR/dissolved formulation    |
| [Souliman 2006](#main-references) | 500 mg | Oral| single-dose, fasted-state| IR/dissolved formulation    |
| [Dalton 2001](#main-references) | 650 mg | Oral| single-dose, fasted-state| IR/dissolved formulation   |
| [Rawlins 1977](#main-references) | 500, 1000 mg | Oral|single-dose, fasted-state|IR/dissolved formulation |
| [Paintaud 1998](#main-references) | 1000 mg | Oral| single-dose, fed-state| IR/dissolved formulation    |
| [Novo Nordisk 2012](#main-references) | 1500 mg | Oral| single-dose, fed-state| IR/dissolved formulation    |
| [Rawlins 1977](#main-references) |2000 mg | Oral| single-dose,  fed-state| IR/dissolved formulation |
| [Albert 1974](#main-references) | 325 mg | Oral| single-dose, fasted-state| Capsule    |
| [Volak 2012](#main-references) | 325 mg | Oral| single-dose, fasted-state| Tablet | 
| [Albert 1974](#main-references) | 650 mg | Oral|single-dose, fasted-state| Tablet | 
| [Dalton 2001](#main-references) | 750 mg | Oral| single-dose, fasted-state| Matrix Tablet    |
| [Dalton 2001](#main-references) | 750 mg | Oral| single-dose, fasted-state| RingCap banded Matrix tablet    |
| [Divoll 1982](#main-references) | 650 mg | Oral| single-dose, fasted-state| RingCap banded Matrix tablet    |



